Synthomer (SYNT): Broadened divestment programme
This situation live
SYNT Synthomer
23 Oct 2025 · Pipeline progressing after William Blythe sale · −4% until the next step
we continue to progress the Group's broadened divestment pipeline in order to accelerate the Group's deleveraging and simplify the portfolio further.
29 Jan 2026 · Pipeline progressing; no new deal announced · −52% until the next step
Having divested William Blythe in May 2025, we continue to progress the Group's broadened divestment pipeline in order to support deleveraging and simplify the portfolio further.
19 Mar 2026 · Progressing constructively; no deal announced · +165% until the next step
These discussions are proceeding constructively, alongside our ongoing focus on delivering the broadened divestment programme.
30 Apr 2026 · Four projects underway; no deal announced · +42% until the next step
Broadened portfolio of four divestment projects underway
22 Jun 2026 · First deal (Acrylate Monomers) announced; others continuing · +1% until the next step
Last week we announced the divestment of the Acrylate Monomers business and we continue to progress other non-core divestment processes to accelerate the Group's deleveraging and simplify the business
4 Aug 2026 · Acrylate Monomers announced; three more underway · +6% until the next step
Three further divestment processes underway to enhance strategic focus and efficiency, simplify manufacturing and reduce debt
30 Sep 2026 · Acrylate Monomers sale completed; three processes continue · +8% since
announces the completion of its divestment of Synthomer a.s., the operating company for its Acrylate Monomers business based in the Czech Republic, in line with the terms announced on 19 June 2026.
Broadened divestment programme
Acrylate Monomers sale completed; three processes continue
Next: Update on three further divestment processes
Every step · 7
- 23 Oct 2025 Pipeline progressing after William Blythe sale – we continue to progress the Group's broadened divestment pipeline in order to accelerate the Group's deleveraging and simplify the portfolio further. ↗
- 29 Jan 2026 Pipeline progressing; no new deal announced – Having divested William Blythe in May 2025, we continue to progress the Group's broadened divestment pipeline in order to support deleveraging and simplify... ↗
- 19 Mar 2026 Progressing constructively; no deal announced – These discussions are proceeding constructively, alongside our ongoing focus on delivering the broadened divestment programme. ↗
- 30 Apr 2026 Four projects underway; no deal announced – Broadened portfolio of four divestment projects underway ↗
- 22 Jun 2026 First deal (Acrylate Monomers) announced; others continuing – Last week we announced the divestment of the Acrylate Monomers business and we continue to progress other non-core divestment processes to accelerate the... ↗
- 4 Aug 2026 Acrylate Monomers announced; three more underway – Three further divestment processes underway to enhance strategic focus and efficiency, simplify manufacturing and reduce debt ↗
- 30 Sep 2026 Acrylate Monomers sale completed; three processes continue – announces the completion of its divestment of Synthomer a.s., the operating company for its Acrylate Monomers business based in the Czech Republic, in line... ↗
What is happening
Synthomer: Broadened divestment programme – Acrylate Monomers sale completed; three processes continue. ['Acrylate Monomers sale completed; three processes continue']
- In short
- Divestment programme broadened Oct 2025. Acrylate Monomers sale announced 19 June 2026 and shown as discontinued in the 4 Aug 2026 interims (H1 EBITDA £(0.4)m). Completed on 30 Sep 2026 in line with the announced terms. Price and buyer are not stated here. Three further processes are underway, and the Dec 2026 leverage target excludes further divestments.
- Announced
- 23 Oct 2025 · Pipeline progressing after William Blythe sale
- Latest
- 30 Sep 2026 · Acrylate Monomers sale completed; three processes continue
- Price
- Not stated in this announcement
- Use of money
- Simplify manufacturing and reduce debt
- Other projects
- Three further divestment processes underway (per 4 Aug 2026 interims)
- Next milestone
- Interim results on 4 August 2026
- Buyer
- Not stated in this announcement
- Leverage target
- Dec 2026 covenant net debt:EBITDA 4.0-4.35x, excluding further divestments
- Completed
- 30 September 2026, in line with terms announced 19 June 2026
- Accounting
- Discontinued operation in interims to 30 June 2026
What comes next
Update on three further divestment processes.
Briefing Pro
New to Synthomer? Get up to speed in 2 minutes.
What it does, how it got here, what management promised and delivered – written from its own announcements.
Get the SYNT briefing →From the company's own announcements. Not investment advice.
Also at Synthomer 1 open
Turnaround plan with targetsCost savings programme – c.£13m delivered in H1 2026
Balance-sheet stress / refinancingDebt refinancing and possible capital raise – Refinanced to 2029; covenants reset · closed
Insider conviction1 director buying – £31k in 1 buy · closed
Insider conviction4 directors buying – £87k in 4 buys · closed
Synthomer – company page →